TRVI
Trevi Therapeutics Inc
14.70$
+1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +8.6% | -5.3% | +5.6% | -2.6% | +2.7% | – | – | +9.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.1% | +35.1% | +13.8% | +12.0% | -16.9% | -16.3% | +20.2% | +7.4% | -38.6% | +60.5% | +52.4% | – | |
| – | -11.3% | +28.4% | +5.4% | -12.4% | +1.8% | +25.5% | +18.4% | -11.6% | +5.1% | +23.4% | +7.8% | – | |
| – | -1.6% | +33.4% | +11.6% | +6.3% | -13.4% | -6.0% | +19.6% | +1.4% | -26.6% | +45.9% | +37.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +33.3% | -75.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -144.4% | – | – | – | -168.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.